Index by author

October 01, 1990; Volume 57,Issue 7

  1. Ahmad, Muzaffar

    1. The effects of steroid therapy on pulmonary hypertension secondary to fibrosing mediastinitis
      Edward M. Cordasco, DO, Muzaffar Ahmad, MD, Atul Mehta, MD and Felipe Rubio, MD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 647-652;

      Steroid therapy can be used most effectively if hemodynamic and scintigraphic studies are performed before and after a therapeutic trial.

  2. Avashia, Jay H.

    1. Metastatic carcinoma of the prostate with hypercalcemia
      Jay H. Avashia, MD, T. Declan Walsh, MSC, Anthony J. Thomas, MD, Mitchell Kaye, MD and Angelo Licata, MD, PHD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 636-638;

      Hypercalcemia in a patient with advanced prostatic cancer was probably a metabolic complication.

  3. Boutros, Azmy R.

    1. Perioperative management of 63 patients with pheochromocytoma
      Azmy R. Boutros, MB, FF ARCS, FRCP, Emmanuel L. Bravo, MD, Giorgio Zanettin, MD and Ralph A. Straffon, MD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 613-617;

      Pheochromocytoma patients can undergo successful surgery without preoperative profound alpha-adrenergic blockade.

  4. Bravo, Emmanuel L.

    1. Perioperative management of 63 patients with pheochromocytoma
      Azmy R. Boutros, MB, FF ARCS, FRCP, Emmanuel L. Bravo, MD, Giorgio Zanettin, MD and Ralph A. Straffon, MD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 613-617;

      Pheochromocytoma patients can undergo successful surgery without preoperative profound alpha-adrenergic blockade.

  5. Brouhard, Ben H.

    1. Lipoprotein abnormalities in the progression of renal disease
      Michael D. Cressman, DO, Kimberly C. Irwin, MD and Nicholas T. Stowe, PhD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 599-604;

      Animal models suggest that lipid-dowering agents may benefit patients with chronic progressive renal disease.

  6. Collins, Robert L.

    1. Pneumomediastinum and subcutaneous emphysema during laparoscopy
      Santosh B. Kalhan, MBBS, John A. Reaney, MD and Robert L. Collins, MD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 639-642;

      Pneumomediastinum and massive subcutaneous emphysema developed during a diagnostic and operative laparoscopy with laser fulguration of endometriosis.

  7. Cordasco, Edward M.

    1. The effects of steroid therapy on pulmonary hypertension secondary to fibrosing mediastinitis
      Edward M. Cordasco, DO, Muzaffar Ahmad, MD, Atul Mehta, MD and Felipe Rubio, MD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 647-652;

      Steroid therapy can be used most effectively if hemodynamic and scintigraphic studies are performed before and after a therapeutic trial.

  8. Cressman, Michael D.

    1. Lipoprotein abnormalities in the progression of renal disease
      Michael D. Cressman, DO, Kimberly C. Irwin, MD and Nicholas T. Stowe, PhD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 599-604;

      Animal models suggest that lipid-dowering agents may benefit patients with chronic progressive renal disease.

  9. Hoogwerf, Byron J.

    1. Managing diabetic retinopathy
      Z. Nicholas Zakov, MD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 609-612;

      A team approach involving an ophthalmologist, endocrinologist, and primary care physician is the key to successful management of diabetic retinopathy.

    2. Visual compromise in the diabetic patient
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 605;

      The importance of an aggressive approach to diagnosis, management, and follow-up of diabetic retinopathy cannot be overstated.

  10. Irwin, Kimberly C.

    1. Lipoprotein abnormalities in the progression of renal disease
      Michael D. Cressman, DO, Kimberly C. Irwin, MD and Nicholas T. Stowe, PhD
      Cleveland Clinic Journal of Medicine October 1990, 57 (7) 599-604;

      Animal models suggest that lipid-dowering agents may benefit patients with chronic progressive renal disease.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue